Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MOTION: Tylenol/Ibuprofen vs. Oral Steroids in Acute MSK Pain
NCT07393503Phase 4Enrolling by invitation
- Sponsor
- University at Buffalo
- Start
- Sep 2025
- Primary completion
- Jan 2027
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 4, randomised trial of methylprednisolone in Musculoskeletal pain (2 arms), sponsored by University at Buffalo. Primary endpoint: Change in Pain at 1 month. Started Sep 2025; status: enrolling by invitation.
02
Drugs
methylprednisolone
03
Conditions
Musculoskeletal pain
Beyond the preview
Go deeper on NCT07393503.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07393503.